Published in Am J Public Health on October 01, 2000
Vaccination coverage and timeliness in three South African areas: a prospective study. BMC Public Health (2011) 1.30
Synthesizing epidemiological and economic optima for control of immunizing infections. Proc Natl Acad Sci U S A (2011) 1.27
Current trends of immunization in Nigeria: prospect and challenges. Trop Med Health (2014) 1.26
Target analysis of the experimental measles therapeutic AS-136A. Antimicrob Agents Chemother (2009) 1.07
Think globally, act locally: the role of local demographics and vaccination coverage in the dynamic response of measles infection to control. Philos Trans R Soc Lond B Biol Sci (2013) 1.02
Biological feasibility of measles eradication. J Infect Dis (2011) 1.01
Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination. Trop Med Int Health (2014) 0.95
Measles control--can measles virus inhibitors make a difference? Curr Opin Investig Drugs (2009) 0.95
Comparison of the immune responses induced by chimeric alphavirus-vectored and formalin-inactivated alum-precipitated measles vaccines in mice. PLoS One (2010) 0.83
Neutralization of measles virus infectivity and antibody-dependent cell-mediated cytotoxicity activity against an Epstein-Barr virus-infected cell line by intravenous immunoglobulin G [corrected]. Clin Diagn Lab Immunol (2003) 0.80
Spatial clustering of measles cases during endemic (1998-2002) and epidemic (2010) periods in Lusaka, Zambia. BMC Infect Dis (2015) 0.78
Epidemic cycling in a multi-strain SIRS epidemic network model. Theor Biol Med Model (2016) 0.75
A review of factors affecting vaccine preventable disease in Japan. Hawaii J Med Public Health (2014) 0.75
Progress in the elimination of measles and congenital rubella in Central Italy. Hum Vaccin Immunother (2013) 0.75
Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ (1999) 4.80
The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med (1994) 4.41
Measles elimination in the Americas. Evolving strategies. JAMA (1996) 3.82
Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J Virol (1990) 3.60
Vaccination and herd immunity to infectious diseases. Nature (1985) 3.58
Measles endemicity in insular populations: critical community size and its evolutionary implication. J Theor Biol (1966) 3.18
Role of schools in the transmission of measles in rural Senegal: implications for measles control in developing countries. Am J Epidemiol (1999) 2.12
The role of secondary vaccine failures in measles outbreaks. Am J Public Health (1989) 2.10
Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J (1990) 1.70
Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. J Clin Microbiol (1991) 1.68
Molecular epidemiology of measles virus: identification of pathways of transmission and implications for measles elimination. J Infect Dis (1996) 1.66
Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset. J Infect Dis (1997) 1.56
Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies. Am J Epidemiol (1999) 1.48
Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection. J Med Virol (1993) 1.31
Alternative routes of measles immunization: a review. Biologicals (1997) 1.27
Vaccination in pulses: a strategy for global eradication of measles and polio? Trends Microbiol (1997) 1.19
Secondary failure rates of measles vaccines: a metaanalysis of published studies. Pediatr Infect Dis J (1996) 1.15
Review of regional measles surveillance data in the Americas, 1996-99. Lancet (2000) 1.13
Performance of indirect immunoglobulin M (IgM) serology tests and IgM capture assays for laboratory diagnosis of measles. J Clin Microbiol (2000) 1.11
The effect of dose and strain of live attenuated measles vaccines on serological responses in young infants. Biologicals (1995) 1.09
Implications of the human immunodeficiency virus epidemic for control and eradication of measles. Clin Infect Dis (1999) 1.07
Clinical efficacy of measles vaccine during the 1990 measles epidemic. Pediatr Infect Dis J (1991) 1.04
Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa. Lancet (1999) 1.02
An evaluation of measles revaccination among school-entry-aged children. Pediatrics (1996) 0.94
Towards eradication of measles virus: global progress and strategy evaluation. Vet Microbiol (1995) 0.91
A model to estimate the potential economic benefits of measles eradication for the United States. Vaccine (1998) 0.83
Measles vaccine effectiveness and duration of vaccine-induced immunity in the absence of boosting from exposure to measles virus. Pediatr Infect Dis J (1996) 0.83
A program for surveillance of nonhuman primate disease. Lab Anim Sci (1971) 0.82
Trends in importation of measles to the United States, 1986-1994. JAMA (1997) 0.82
Epidemic measles in the postvaccine era: evaluation of epidemiology, clinical presentation and complications during an urban outbreak. Pediatr Infect Dis J (1993) 0.82
Failure of vaccinated children to transmit measles. JAMA (1973) 0.81
Persistent measles infection of the central nervous system: subacute sclerosing panencephalitis. Rev Infect Dis (1983) 0.81
South Africa's new enemy. Science (2000) 0.78
Pasteurized milk as a vehicle of infection in an outbreak of listeriosis. N Engl J Med (1985) 11.94
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA (1993) 4.63
A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med (1995) 4.21
Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis (1999) 3.48
Measles virus P gene codes for two proteins. J Virol (1985) 3.31
Cost-effectiveness of a routine varicella vaccination program for US children. JAMA (1994) 3.27
Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. JAMA (1991) 3.09
Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitis. N Engl J Med (1995) 2.81
Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union. Lancet (1996) 2.78
Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet (1991) 2.64
Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology (2000) 2.63
Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis (1992) 2.55
Multidrug-resistant tuberculosis in the New York State prison system, 1990-1991. J Infect Dis (1994) 2.45
Molecular biology of Hendra and Nipah viruses. Microbes Infect (2001) 2.33
Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol (1998) 2.24
Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation, and control. Clin Infect Dis (1993) 2.21
Subacute sclerosing panencephalitis in the differential diagnosis of encephalitis. Neurology (2004) 2.18
Expression of the gene encoding the 17-kilodalton antigen from Rickettsia rickettsii: transcription and posttranslational modification. J Bacteriol (1988) 2.14
Differential diagnosis of acute flaccid paralysis and its role in poliomyelitis surveillance. Epidemiol Rev (2000) 2.06
The Vaccine Adverse Event Reporting System (VAERS). Vaccine (1994) 2.02
Stopping poliovirus vaccination after eradication: issues and challenges. Bull World Health Organ (2000) 2.00
Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center. JAMA (1997) 1.99
Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment. JAMA (1985) 1.91
Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology (1992) 1.89
Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus Res (1994) 1.89
A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells. J Virol (1998) 1.88
Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays. J Clin Microbiol (1992) 1.87
Experimental measles. I. Pathogenesis in the normal and the immunized host. Virology (1997) 1.83
Acquired immunodeficiency syndrome in low-incidence areas. How safe is unsafe sex? JAMA (1987) 1.81
Pertussis deaths: report of 23 cases in the United States, 1992 and 1993. Pediatrics (1996) 1.79
Use of antibodies directed against synthetic peptides for identifying cDNA clones, establishing reading frames, and deducing the gene order of measles virus. J Virol (1985) 1.75
Matrix genes of measles virus and canine distemper virus: cloning, nucleotide sequences, and deduced amino acid sequences. J Virol (1986) 1.74
Pertussis hospitalizations and mortality in the United States, 1985-1988. Evaluation of the completeness of national reporting. JAMA (1992) 1.74
Clinical isolates of measles virus use CD46 as a cellular receptor. J Virol (2000) 1.72
Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. J Clin Microbiol (1991) 1.68
Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2000) 1.67
Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review. Clin Infect Dis (2000) 1.67
Molecular epidemiology of measles virus: identification of pathways of transmission and implications for measles elimination. J Infect Dis (1996) 1.66
Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule. JAMA (1996) 1.64
Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains. J Infect Dis (1999) 1.62
Sequence analysis of the 17-kilodalton-antigen gene from Rickettsia rickettsii. J Bacteriol (1987) 1.61
Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease. Emerg Infect Dis (1998) 1.57
Childhood upper respiratory tract infections: to what degree is incidence affected by day-care attendance? Pediatrics (1987) 1.57
Sequence homology within the morbilliviruses. J Virol (1985) 1.56
Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset. J Infect Dis (1997) 1.56
Epidemiological features of pertussis in the United States, 1980-1989. Clin Infect Dis (1992) 1.55
Reporting efficiency during a measles outbreak in New York City, 1991. Am J Public Health (1993) 1.53
Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication. Int J Epidemiol (2001) 1.53
Invited commentary: vaccine failure or failure to vaccinate? Am J Epidemiol (1999) 1.49
Accumulated measles virus mutations in a case of subacute sclerosing panencephalitis: interrupted matrix protein reading frame and transcription alteration. Virology (1986) 1.49
Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies. Am J Epidemiol (1999) 1.48
Molecular characterization of the polymerase gene and genomic termini of Nipah virus. Virology (2001) 1.47
Comment: ethical dilemmas in worldwide polio eradication programs. Am J Public Health (1997) 1.44
Exudative pharyngitis possibly due to Corynebacterium pseudodiphtheriticum, a new challenge in the differential diagnosis of diphtheria. Emerg Infect Dis (1997) 1.43
New genetic group of measles virus isolated in the People's Republic of China. Virus Res (1998) 1.42
Molecular epidemiology of measles virus. Curr Top Microbiol Immunol (2009) 1.41
Primary invasive Haemophilus influenzae type b disease: a population-based assessment of risk factors. J Pediatr (1986) 1.40
Vaccine-associated paralytic poliomyelitis. N Engl J Med (1993) 1.39
Spontaneous mutation rate of measles virus: direct estimation based on mutations conferring monoclonal antibody resistance. J Virol (1999) 1.38
Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination. Clin Infect Dis (1998) 1.38
Genetic analysis of measles viruses isolated in the United States, 1995-1996. J Infect Dis (1998) 1.36
Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection. J Med Virol (1993) 1.31
Evolution of the nucleoprotein and matrix genes of wild-type strains of measles virus isolated from recent epidemics. Virology (1994) 1.31
Mumps outbreak in a highly vaccinated population. J Pediatr (1991) 1.30
Molecular epidemiology of Bordetella pertussis by pulsed-field gel electrophoresis profile: Cincinnati, 1989-1996. J Infect Dis (2001) 1.29
Vaccine prevention of Haemophilus influenzae type b disease: past, present and future. Pediatr Infect Dis (1986) 1.27
Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease. Arch Pediatr Adolesc Med (1994) 1.23
Outbreaks of paralytic poliomyelitis, 1976-1995. J Infect Dis (1997) 1.20
Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am J Epidemiol (1994) 1.20
Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication. Clin Infect Dis (2001) 1.20
Excess mortality from stomach cancer, lung cancer, and asbestosis and/or mesothelioma in crocidolite mining districts in South Africa. Am J Epidemiol (1986) 1.20
Localization of monoclonal antibody epitopes and functional domains in the hemagglutinin protein of measles virus. J Virol (1995) 1.19
Detection of measles virus RNA in urine specimens from vaccine recipients. J Clin Microbiol (1995) 1.19
Genetic characterization of contemporary wild-type measles viruses from Vietnam and the People's Republic of China: identification of two genotypes within clade H. Virus Res (2001) 1.18
Disease eradication as a public health strategy: a case study of poliomyelitis eradication. Bull World Health Organ (2000) 1.18
Assessment of vital statistics and surveillance data for monitoring tetanus mortality, United States, 1979-1984. Am J Epidemiol (1990) 1.18
Mumps transmission in hospitals. Arch Intern Med (1990) 1.14
Timing of development of measles-specific immunoglobulin M and G after primary measles vaccination. Clin Diagn Lab Immunol (1999) 1.14
National immunization days: state of the art. J Infect Dis (1997) 1.12
Positive identification of a measles virus cDNA clone encoding a region of the phosphoprotein. J Virol (1984) 1.11
Preventing rubella: assessing missed opportunities for immunization. Am J Public Health (1987) 1.11
Tetanus surveillance--United States, 1989-1990. MMWR CDC Surveill Summ (1992) 1.09
Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection. Am J Epidemiol (1994) 1.09
A large outbreak of mumps in the postvaccine era. J Infect Dis (1988) 1.08
Measles virus strain variations. Curr Top Microbiol Immunol (1995) 1.08
The diversity of measles virus in the United Kingdom, 1992-1995. J Gen Virol (1997) 1.08
Nonclassic measles infections in an immune population exposed to measles during a college bus trip. J Med Virol (1998) 1.08